| Item Type | Name |
|
Academic Article
|
Immunologic aspects of surface infections in the lung.
|
|
Academic Article
|
Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.
|
|
Academic Article
|
Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
|
|
Academic Article
|
Influenza virus pneumonia: pathogenesis, treatment, and prevention.
|
|
Academic Article
|
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.
|
|
Academic Article
|
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
|
|
Academic Article
|
Maternal immunization against viral disease.
|
|
Academic Article
|
Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
|
|
Academic Article
|
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
|
|
Academic Article
|
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
|
|
Academic Article
|
Influenza virus infections in infants.
|
|
Academic Article
|
Respiratory syncytial virus vaccines: recent developments.
|
|
Academic Article
|
Clinical experience with respiratory syncytial virus vaccines.
|
|
Academic Article
|
Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.
|
|
Academic Article
|
Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.
|
|
Academic Article
|
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis.
|
|
Academic Article
|
Safety of cold-adapted live influenza vaccine.
|
|
Academic Article
|
Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines.
|
|
Academic Article
|
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
|
|
Academic Article
|
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
|
|
Academic Article
|
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.
|
|
Academic Article
|
Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus.
|
|
Academic Article
|
Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease.
|
|
Academic Article
|
Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
|
|
Academic Article
|
Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.
|
|
Academic Article
|
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
|
|
Academic Article
|
Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients.
|
|
Academic Article
|
Future directions in vaccine prevention of respiratory syncytial virus.
|
|
Academic Article
|
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women.
|
|
Academic Article
|
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
|
|
Academic Article
|
Immunization against viral respiratory disease: a review.
|
|
Academic Article
|
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
|
|
Academic Article
|
Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
|
|
Academic Article
|
Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
|
|
Academic Article
|
Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.
|
|
Concept
|
Vaccines, Inactivated
|
|
Concept
|
Vaccines
|
|
Concept
|
Vaccines, Attenuated
|
|
Concept
|
Viral Vaccines
|
|
Concept
|
Pseudomonas Vaccines
|
|
Concept
|
Vaccines, Synthetic
|
|
Concept
|
Vaccines, Combined
|
|
Concept
|
Influenza Vaccines
|
|
Concept
|
Vaccines, Virosome
|
|
Concept
|
Bacterial Vaccines
|
|
Concept
|
Respiratory Syncytial Virus Vaccines
|
|
Concept
|
Vaccines, Subunit
|
|
Academic Article
|
[Universal immunisation against influenza in paediatrics, yes or no?].
|
|
Academic Article
|
Influenza A(H5N1) vaccines: are we better prepared for the next pandemic?
|
|
Academic Article
|
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.
|
|
Academic Article
|
Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.
|
|
Academic Article
|
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.
|
|
Academic Article
|
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.
|
|
Academic Article
|
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.
|
|
Academic Article
|
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
|
|
Academic Article
|
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.
|
|
Academic Article
|
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
|
|
Academic Article
|
A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.
|
|
Academic Article
|
Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
|
|
Academic Article
|
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
|
|
Academic Article
|
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.
|
|
Academic Article
|
Local Versus Global Enterovirus (EV) Surveillance: A Discussion for the Need for Active Surveillance to Guide EV-A71 Vaccines.
|
|
Academic Article
|
Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.
|
|
Academic Article
|
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
|
|
Academic Article
|
Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
|
|
Academic Article
|
Live Attenuated Influenza Vaccine: Will the Phoenix Rise Again?
|
|
Concept
|
Vaccines, Virus-Like Particle
|
|
Academic Article
|
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
|
|
Academic Article
|
Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
|
|
Academic Article
|
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
|
|
Academic Article
|
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
|
|
Academic Article
|
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
|
|
Academic Article
|
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.
|
|
Academic Article
|
A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
|
|
Academic Article
|
Profile of respiratory syncytial virus prefusogenic fusion protein nanoparticle vaccine.
|
|
Academic Article
|
Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology.
|
|
Academic Article
|
Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
|
|
Academic Article
|
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.
|
|
Academic Article
|
Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
|
|
Academic Article
|
Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020.
|
|
Academic Article
|
The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
|
|
Academic Article
|
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
|